Letter:

We read with much interest the article "Acute Stroke Management During the Coronavirus Disease 2019 (COVID-19) Pandemic: From Trough of Disillusionment to Slope of Enlightenment" published by Kasab et al[@bib1] in your esteemed journal. In this article the authors have discussed in detail the multifaceted approach to stroke care in the form of thrombectomy in large vessel occlusions.[@bib1] We believe that literature on presentation and management of stroke in patients with COVID-19 is an evolving topic. COVID-19, which is an illness of international concern, continues to affect a large number of patients with each passing day.[@bib2] Literature on stroke in patients with COVID-19 has been limited. In this letter we hope to summarize the literature available on the clinical aspect of acute stroke among patients with COVID-19.

COVID-19 and Prior Cerebrovascular Event {#sec1}
========================================

Presence of cerebrovascular events have been reported in \<2% of patients with severe COVID-19. A recent study by Aggarwal et al[@bib3] on patients with possible cerebrovascular disease and COVID-19 had identified 4 studies with 1829 patients with COVID-19. Among these, 49 (2.9%) patients had a history of cerebrovascular disease. They reported that the presence of cerebrovascular disease was associated with an increased risk of severe COVID-19. This association was statistically significant; patients with prior stroke had a 2.5-fold increase in odds of severe COVID-19.[@bib3]

COVID-19 and New-Onset Cerebrovascular Event {#sec2}
============================================

Multiple reports have documented new-onset cerebrovascular events in patients with COVID-19. Presence of low sensorium, focal neurologic deficit, and low Glasgow Coma Scale in patients with severe COVID-19 have been instrumental in suspecting this diagnosis.[@bib4] Most studies have reported computed tomography imaging of the brain in these patients. Anecdotal reports of magnetic resonance imaging of brain are also available in literature. Patients with severe COVID-19 are more prone to have these events. In a recent review, these events have been shown to predict disease severity.[@bib5]

COVID-19 and Treatment-Related Cerebrovascular Events {#sec3}
=====================================================

Multiple mechanisms of lung, cardiac, neurologic, and endothelial injury have been postulated in patients with COVID-19.[@bib6] One of the mechanisms that has been targeted for treatment is injury secondary to embolism in the background of prothrombotic state.[@bib7] This has been looked into due to the increased embolic events among patients with severe COVID-19, requiring intensive care unit admission and invasive mechanical ventilation. These have also been shown to predict disease severity and mortality. There has been a recent surge of administering therapeutic anticoagulation in patients with elevated D-dimer with and without evident embolism, which has its own challenges. A recent study reported 33 patients of COVID-19 with intracranial hemorrhage while receiving therapeutic anticoagulation with unfractionated heparin or enoxaparin. Mortality in this group was 15.2% and was directly related to raised intracranial pressure. Interestingly, only 20% of patients in this study were on any antiplatelet agents before the diagnosis of COVID-19.[@bib8] In another study the authors reported diffuse intraparenchymal hemorrhage in 3 COVID-19 patients who underwent diagnostic intracerebral biopsy.[@bib9] Authors in this study hypothesized that active COVID-19 infection might predispose to increased risk of bleeding.[@bib9] Hydroxychloroquine has also been used extensively during this pandemic. It has been shown to reduce the rates of acute myocardial infarction and cerebrovascular events in prior studies.[@bib10]

In conclusion, the interaction between COVID-19 and cerebrovascular events is complex.[@bib2] Notably, patients with severe COVID-19 are more prone to have had a prior stroke or to develop a new-onset stroke. [Figure 1](#fig1){ref-type="fig"} shows the mechanisms, interactions, and outcome of cerebrovascular events in COVID-19 patients.[@bib11] Treatment-related hemorrhage is significant and contributory to outcome. In patients with COVID-19 presenting with large vessel occlusion resulting in stroke, factors including severity of COVID-19, extent of other organ involvement including acute respiratory distress syndrome, acute myocardial injury, acute kidney injury, level of inflammatory markers, presence of systemic prothrombotic state, and various treatment-related factors should be incorporated into the treatment algorithm.[@bib12] ^,^ [@bib13] Figure 1Factors affecting cerebrovascular events in patients with COVID-19.
